Cargando…

Contemporary use of lipid-lowering therapy for secondary prevention in Korean patients with atherosclerotic cardiovascular diseases

BACKGROUND/AIMS: We evaluated the contemporary use of lipid-lowering therapy (LLT) in Korean patients with atherosclerotic cardiovascular disease (ASCVD), and identified factors associated with statin non-prescription. METHODS: Using the Korean Health Insurance Review and Assessment data, we identif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Su-Yeon, Yang, Bo Ram, Kang, Hyun-Jae, Park, Kyong Soo, Kim, Hyo-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214354/ https://www.ncbi.nlm.nih.gov/pubmed/31752475 http://dx.doi.org/10.3904/kjim.2018.312

Ejemplares similares

Exploring Contemporary Data on Lipid-Lowering Therapy Prescribing in Patients Following Discharge for Atherosclerotic Cardiovascular Disease in the South of Italy
por: Citarella, Anna, et al.
Publicado: (2022)

Low-density lipoprotein cholesterol lowering therapy for the secondary prevention of atherosclerotic cardiovascular disease
por: Patel, Parth N., et al.
Publicado: (2020)

Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort
por: Bae, Jae Hyun, et al.
Publicado: (2020)

Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
por: Bi, Lei, et al.
Publicado: (2022)

Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
por: Michaeli, Daniel Tobias, et al.
Publicado: (2023)

Integrated Analysis of Two Probucol Trials for the Secondary Prevention of Atherosclerotic Cardiovascular Events: PROSPECTIVE and IMPACT
por: Arai, Hidenori, et al.
Publicado: (2022)

Contemporary Koreans’ Perceptions of Facial Beauty
por: Rhee, Seung Chul, et al.
Publicado: (2017)

Role of Different Low-Density Lipoprotein-Lowering Medications on Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients With Diabetes Mellitus
por: Saag, Jordan L, et al.
Publicado: (2023)

Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline
por: Journath, Gunilla, et al.
Publicado: (2017)

Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease
por: Desai, Nihar R., et al.
Publicado: (2022)

Moving toward combination lipid-lowering therapy for all patients with atherosclerotic cardiovascular disease
por: Faridi, Kamil F., et al.
Publicado: (2023)

Systematic review of clinical guidelines for lipid lowering in the secondary prevention of cardiovascular disease events
por: Brown, Rosemary Elisabeth, et al.
Publicado: (2020)

Secondary Prevention Using Cholesterol-Lowering Medications in Patients with Prior Atherosclerotic Cardiovascular Disease Events: A Retrospective Cohort Analysis
por: Han, Xue, et al.
Publicado: (2022)

Contemporary follow-up imaging after endovascular repair of lower extremity atherosclerotic lesions
por: Michalska, Marta, et al.
Publicado: (2018)

Prediction of the 10-year risk of atherosclerotic cardiovascular disease in the Korean population
por: Park, Sangwoo, et al.
Publicado: (2023)

Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease
por: Albosta, Michael S, et al.
Publicado: (2023)

Association of genetic variations with pharmacokinetics and lipid-lowering response to atorvastatin in healthy Korean subjects
por: Woo, Hye In, et al.
Publicado: (2017)

Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses
por: Shaya, Fadia Tohme, et al.
Publicado: (2019)

Contemporary Status of Acute Myocardial Infarction in Korean Patients: Korean Registry of Acute Myocardial Infarction for Regional Cardiocerebrovascular Centers
por: Kim, Rock Bum, et al.
Publicado: (2021)

Korean guidelines for the management of gout
por: Lee, Jennifer Jooha, et al.
Publicado: (2023)

Korean guidelines for the management of gout
por: Lee, Jennifer Jooha, et al.
Publicado: (2023)

Underuse of statins for secondary prevention of atherosclerotic cardiovascular disease events among ambulatory surgical patients
por: Schonberger, Robert B., et al.
Publicado: (2020)

The effect of telemedicine on secondary prevention of atherosclerotic cardiovascular disease: A systematic review and meta-analysis
por: Deng, Liangying, et al.
Publicado: (2022)

Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
por: Nelson, Adam J., et al.
Publicado: (2022)

The Role of Lipid-Lowering Treatment in the Secondary Prevention of Ischemic Stroke
por: Tsankof, Alexandra, et al.
Publicado: (2021)

Total and differential WBC counts are related with coronary artery atherosclerosis and increase the risk for cardiovascular disease in Koreans
por: Kim, Jung Hee, et al.
Publicado: (2017)

Cardiovascular Imaging for the Primary Prevention of Atherosclerotic Cardiovascular Disease Events
por: Weber, Lauren A., et al.
Publicado: (2015)

Triglyceride-Glucose Index Predicts Future Atherosclerotic Cardiovascular Diseases: A 16-Year Follow-up in a Prospective, Community-Dwelling Cohort Study
por: Moon, Joon Ho, et al.
Publicado: (2023)

Prior Cancer Is Associated with Lower Atherosclerotic Cardiovascular Disease Risk at First Acute Myocardial Infarction
por: Koo, Chieh Yang, et al.
Publicado: (2022)

Recent Advances in Primary and Secondary Prevention of Atherosclerotic Stroke
por: Tsivgoulis, Georgios, et al.
Publicado: (2018)

Recent Advances in Primary and Secondary Prevention of Atherosclerotic Stroke
por: Tsivgoulis, Georgios, et al.
Publicado: (2018)

Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US
por: Cannon, Christopher P., et al.
Publicado: (2021)

Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease?
por: Poredos, Pavel, et al.
Publicado: (2015)

Access and adherence to medications for the primary and secondary prevention of atherosclerotic cardiovascular disease in Singapore: a qualitative study
por: Koh, Joel Jun Kai, et al.
Publicado: (2018)

A Checklist Approach for Enhanced Outpatient Guideline-Directed Management in the Secondary Prevention of Atherosclerotic Cardiovascular Disease
por: Taha, Mohamad B., et al.
Publicado: (2021)

Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Lipid-Lowering Effects of Pediococcus acidilactici M76 Isolated from Korean Traditional Makgeolli in High Fat Diet-Induced Obese Mice
por: Moon, Yeon-Jeong, et al.
Publicado: (2014)

Lipid Management in Korean People With Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
por: Yang, Ye Seul, et al.
Publicado: (2023)

Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
por: Yang, Ye Seul, et al.
Publicado: (2023)

Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus
por: Choi, Soo-Yeon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s4hsuat6j4e2b518ovkkda6muf